MOS
MRNA icon

MGO One Seven’s Moderna MRNA Stock Holding History

MGO One Seven’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-3,051
Closed -$204K – 1109
2024
Q3 		$204K Sell
3,051
-328
-10% -$30.1K 0.01% 929
2024
Q2 		$401K Sell
3,379
-11
-0.3% -$1.39K 0.02% 645
2024
Q1 		$361K Buy
3,390
+136
+4% +$13.7K 0.02% 664
2023
Q4 		$324K Buy
3,254
+1,495
+85% +$126K 0.02% 681
2023
Q3 		$182K Buy
+1,759
New +$196K 0.01% 763
2021
Q4 		– Sell
-724
Closed -$250K – 687
2021
Q3 		$250K Sell
724
-326
-31% -$120K 0.03% 502
2021
Q2 		$247K Buy
+1,050
New +$188K 0.03% 498

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

MGO One Seven's MRNA Position: Q4 2024 in Review

MGO One Seven sold out of Moderna (MRNA) in Q4 2024, closing a stake of 3,051 shares — an estimated $204K sold.

MGO One Seven first reported a position in MRNA in Q2 2021 and held it in 7 quarters. The position peaked at $401K in Q2 2024. 745 funds tracked by Wall St. Rank hold MRNA as of Q4 2024.

  • MGO One Seven reported no remaining Moderna position as of Q4 2024 after selling out during the quarter.
  • MGO One Seven sold 3,051 Moderna shares in Q4 2024, an estimated $204K.
  • MGO One Seven first reported a position in Moderna in Q2 2021 and held it in 7 quarters.
  • MGO One Seven's Moderna position peaked at $401K in Q2 2024.
  • 745 funds tracked by Wall St. Rank held Moderna as of Q4 2024.

Based on MGO One Seven's 13F filing for Q4 2024, filed 14 Feb 2025.